10. Banisadr G, Fontanges P, Haour F, Kitabgi P, Rostène W,
Parsadaniantz SM. Neuroanatomical distribution of CXCR4 in adult rat
brain and its localization in cholinergic and dopaminergic neurons. Eur
J Neurosci. 2002;16:1661-1671.
11. Mizuno T, Kawanokuchi J, Numata K, Suzumura A. Production and
neuroprotective function of fractalkine in the central nervous system.
Brain Res. 2003;979:65-70.
12. Westmoreland SV, Alvarez X, deBakker C, et al. Developmental
expression patterns of CCR5 and CXCR4 in the rhesus macaque brain.
J Neuroimmunol. 2002;122:146-158.
13. Ragozzino D, Renzi M, Giovannelli A, Eusebi F. Stimulation of
chemokine CXC receptor 4 induces synaptic depression of evoked
parallel fibers inputs onto Purkinje neurons in mouse cerebellum.
J Neuroimmunol. 2002;127:30-36.
14. Cho C, Miller RJ. Chemokine receptors and neural function.
J Neurovirol. 2002;8:573-584.
15. Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of
chemokines and their receptors in the central nervous system:
physiopathological implications. J Neurochem. 2002;82:1311-1329.
16. Zheng J, Thylin MR, Ghorpade A, et al. Intracellular CXCR4
signaling, neuronal apoptosis and neuropathogenic mechanisms of
HIV-1-associated dementia. J Neuroimmunol. 1999;98:185-200.
17. Stumm RK, Rummell J, Junker V, et al. A dual role for the SDF-1/
CXCR4 chemokine receptor system in adult brain: isoform-selective
regulation of SDF-1 expression modulates CXCR4-dependent neuronal
plasticity and cerebral leukocyte recruitment after focal ischemia.
J Neurosci. 2002;22:5865-5878.
18. Szabo I, Chen XH, Xin L, et al. Heterologous desensitization of
opioid receptors by chemokines inhibits chemotaxis and enhances the
perception of pain. Proc Natl Acad Sci USA. 2002;99:10276-10281.
19. Zhang N, Rogers TJ, Caterina M, Oppenheim JJ. Proinflammatory
chemokines, such as C-C chemokine ligand 3, desensitize μ-opioid
receptors on dorsal root ganglia neurons. J Immunol. 2004;173:594-599.
20. Steele AD, Szabo I, Bednar F, Rodgers RJ. Interactions between
opioid and chemokine receptors: heterologous desensitization. Cytokine
Growth Factor Rev. 2002;13:209-222.
21. Rogers TJ, Steele AD, Howard OMZ, Oppenheim JJ. Bidirectional
heterologous desensitization of opioid and chemokine receptors. Ann N
Y Acad Sci. 2000;917:19-28.
22. Szabo I, Wetzel MA, Zhang N, et al. Selective inactivation of CCR5
and decreased infectivity of R5 HIV-1 strains mediated by opioidinduced heterologous desensitization. J Leukoc Biol.
2003;74:1074-1082.
23. Pizziketti RJ, Pressman NS, Geller EB, Cowan A, Adler MW. Rat
cold water tail-flick: a novel analgesic test that distinguishes opioid
agonists from mixed agonist-antagonists. Eur J Pharmacol.
1985;119:23-29.
24. Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen L-Y.
Heterodimerization and cross-desensitization between the μ-opioid
receptor and the chemokine CCR5 receptor. Eur J Pharmacol.
2004;483:175-186.
25. Tran PB, Miller RJ. Chemokine receptors in the brain: a developing
story. J Comp Neurol. 2003;457:1-6.
26. Rogers TJ, Peterson PK. Opioid G protein-coupled receptors:
signals at the crossroads of inflammation. Trends Immunol.
2003;24:116-121.
